ArticleJCEM case reports2025
Diabetic Ketoacidosis-Associated Brain Injury: A Rare but Serious Complication.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hyperglycemia associated brain dysfunction: rodent models for studying diabetic cognitive deficits.Metabolic brain disease · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic ketoacidosis (DKA)-associated brain injury is a rare but serious complication, typically occurring early during metabolic correction and associated with a poor prognosis. We report the case of an 18-year-old college student admitted to the intensive care unit with severe DKA, characterized by profound metabolic acidosis and marked electrolyte imbalances, including hypokalemia, hypernatremia, and hyperchloremia. Within hours, she developed altered mental status and generalized seizures. Brain magnetic resonance imaging (MRI) revealed diffuse cortical and brainstem abnormalities, suggestive of cytotoxic cerebral edema. She was managed with continuous sedation, mechanical ventilation, intravenous insulin, potassium supplementation, enteral nutrition, and gradual metabolic correction. Her neurologic status improved within a few days, and follow-up MRI showed partial regression of the lesions. She was subsequently transferred to the endocrinology department and ultimately regained full cognitive and physical function. This case underscores the importance of early recognition, close neurologic monitoring, timely neuroimaging, and tight metabolic and osmotic control to optimize outcomes in patients with DKA-associated brain injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.